Items where Author is "Xu, B"

Group by: Item Type | No Grouping
Number of items: 5.

XU, B., OWUSU‐MENSAH, R. and GYIMAH, D., 2026. Financial constraints and corporate sustainability performance: do climate exposure and people's climate attention matter? Business Strategy and the Environment. ISSN 0964-4733

ZHANG, S., LIU, Z., JIANG, T., WANG, C., WANG, J., WANG, H., FAN, M., YANG, L., LI, Y., DING, L., YU, Y., HAO, X., MA, S., XU, B., CHEN, X., YE, C., CHEN, X., CHU, P.K., JIN, S., DING, F., YU, X.-F., SUN, Z. and WANG, J., 2026. Strong optical anisotropy in one-dimensional phosphorus wavy tubes. Nature Communications. ISSN 2041-1723

ZHOU, C., XU, B., XU, X. and KANER, J., 2025. Exploring the creation of multi-modal soundscapes in the indoor environment: a study of stimulus modality and scene type affecting physiological recovery. Journal of Building Engineering, 111: 113327. ISSN 2352-7102

XU, B., 2016. Porter's strategy and the influence of guanxi and government policies in small and medium-sized pharmaceutical companies in China. DBA, Nottingham Trent University.

ABDEL-FATAH, T.M.A., AGARWAL, D., LIU, D.X., RUSSELL, R., RUEDA, O.M., LIU, K., XU, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., REES, R.C., CALDAS, C., ELLIS, I.O., BALL, G.R. and CHAN, S.Y.T., 2016. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology, 17 (7), pp. 1004-1018. ISSN 1470-2045

This list was generated on Wed May 13 10:29:19 2026 UTC.